Location: Home
  • search
  • go
  • Relate News
  • 1/10/2024Shenzhen Becomes First City To Allow Nurses To Prescribe Drugs
  • 1/10/2024CDE Issues the Technical Guidelines on Pharmacokinetic-based Support f...
  • 1/10/2024Coherus Ends TIGIT Collaboration with Junshi After $35M Bet
  • 1/10/2024Chinese Pharma Firms Eye Singapore as Springboard for Global Ambition
  • 1/10/2024MSD Gets Chinese Approval to Cut 9vHPV Vaccine Doses for Girls Aged 9-...
  • 1/10/2024WuXi Biologics Expands Manufacturing Capacity in the US
  • 1/10/2024Can China Halt the Exodus from Its State Health Insurance Scheme as En...
  • 1/9/2024Chinese Patent Examination Guidelines 2023 – Toby's Observations
  • 1/9/2024The NHC Issues the Guidelines for the Clinical Application of New Anti...
  • 1/9/2024NHSA: Average Price of Drugs under Price Review Slashed by Over 40% in...
  • 1/9/2024J&J to Acquire China-linked Ambrx, Advancing Next Generation ADCs to ...
  • 1/9/2024Biogen, Eisai Granted Chinese Approval of Their Alzheimer's Drug Leqem...
  • 1/9/20242024 National Healthcare Security Work Conference Held in Beijing to S...
  • 1/8/2024Snapshot Review of Ten Terminated Major Global Deals
  • 1/8/2024PharmCube: 20 Blockbuster New Drugs Are Expected to Receive Chinese Ap...
  • 1/8/2024Top Ten Cross-Border Out-licensing Deals of Domestic Innovative Drugs ...
  • 1/8/2024Top 20 Chemical Drugs by Sales at Chinese Retail Pharmacies 01-09/2023
  • 1/8/2024Pharnexcloud: 18 Domestic New Drugs Likely to be Approved in China 202...
  • 1/8/2024Novartis and Argo Enter Multi-Program RNAi Deals 
  • 1/8/2024Bio-Link and Verdot Enter Strategic Partnership to Advance Bioprocessi...
  • 1/8/2024China Enters the Weight Loss Drug Race with MNCs on Alert
  • 1/8/2024Foreign Drug Giants Shift Strategy on China Sales as Competition Ramps...
  • 1/7/2024Chinese Pharmaceutical Companies Chart New Paths in the Middle East (K...
  • 1/7/2024Why Is TikTok Parent ByteDance Moving into Biology, Chemistry and Drug...
  • 1/7/2024Christmas Present from China – Implementation Regulations of the Chin...
  • 1/7/2024CNIPA to Allow Third-Party Challenges to Pharmaceutical Patent Term Ex...
  • 1/7/2024Praxis and Tenacia Biotech Enter Global Deal for Ulixacaltamide in Gr...
  • 1/7/2024China Expedites Development of County-level Medical Consortiums
  • 1/7/2024NMPA Issues Announcement for Applicability of ICH Guidelines M7(R2)
  • 1/7/2024NMPA Issues the Third-Party Platform Inspection Guidelines for Online ...
  • Page:115/812 Total number of articles:24359: [First][<<] [113] [114] [115] [116] [117] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group